Bear Stalking Biotech Sector
The biotech sector saw a significant run-up last month, but for at least one analyst, questions remain about what the second half holds.
Get updates by email
Editor
Yali Friedman lives in Washington, DC and is author of Building Biotechnology and other books; founder of DrugPatentWatch; and chief editor of the Journal of Commercial Biotechnology.
and Share
Reading
Translator
← Financial Snapshot For June 2005 (previous entry)
(next entry) Overcoming Offshoring in Biotechnology →
© Copyright - BiotechBlog — A thinkBiotech product
Leave a Reply
Want to join the discussion?Feel free to contribute!